BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2869791)

  • 1. Endogenous opioid regulation of hypothalamo-pituitary-adrenal axis activity in schizophrenia.
    Wolkowitz OM; Doran AR; Breier A; Cohen MR; Pickar D
    Biol Psychiatry; 1986 Apr; 21(4):366-73. PubMed ID: 2869791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid modulation of the hypothalamo-pituitary-adrenal axis in dairy cows.
    Nanda AS; Dobson H; Ward WR
    Domest Anim Endocrinol; 1992 Jul; 9(3):181-6. PubMed ID: 1458871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of opioid modulation of the hypothalamo-pituitary-adrenal axis in patients with severe premenstrual syndrome.
    Facchinetti F; Fioroni L; Martignoni E; Sances G; Costa A; Genazzani AR
    Psychosom Med; 1994; 56(5):418-22. PubMed ID: 7809341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of the opioid system in the functional regulation of the hypothalamo-hypophyseal-adrenal system in traumatic shock].
    El'skiĭ VN; Slepushkin VD; Samsonenko RA; Sergeeva LA; Talalaenko VN
    Patol Fiziol Eksp Ter; 1985; (6):15-9. PubMed ID: 3005954
    [No Abstract]   [Full Text] [Related]  

  • 6. [-Effect of endogenous opioids on adrenal cortex activity in women with hypothalamic amenorrhea-].
    Krause BT; Möller S
    Gynakol Geburtshilfliche Rundsch; 1995; 35(4):194-8. PubMed ID: 8646002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic-pituitary-adrenal axis in schizophrenia.
    Altamura AC
    Biol Psychiatry; 1996 Sep; 40(6):560-1. PubMed ID: 8879482
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypothalamic-pituitary-adrenal axis function in chronic schizophrenia: association with clinical features.
    Kaneko M; Yokoyama F; Hoshino Y; Takahagi K; Murata S; Watanabe M; Kumashiro H
    Neuropsychobiology; 1992; 25(1):1-7. PubMed ID: 1351264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antipsychotic treatment on Insulin-like Growth Factor-1 and cortisol in schizophrenia: a longitudinal study.
    Venkatasubramanian G; Chittiprol S; Neelakantachar N; Shetty T; Gangadhar BN
    Schizophr Res; 2010 Jun; 119(1-3):131-7. PubMed ID: 20226630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia.
    Ryan MC; Sharifi N; Condren R; Thakore JH
    Psychoneuroendocrinology; 2004 Sep; 29(8):1065-70. PubMed ID: 15219658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple measures of HPA axis function in ultra high risk and first-episode schizophrenia patients.
    Nordholm D; Rostrup E; Mondelli V; Randers L; Nielsen MØ; Wulff S; Nørbak-Emig H; Broberg BV; Krakauer K; Dazzan P; Zunszain PA; Nordentoft M; Glenthøj B
    Psychoneuroendocrinology; 2018 Jun; 92():72-80. PubMed ID: 29635174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous opioids and hypothalamic-pituitary-adrenal function in obesity and anorexia nervosa.
    Cavagnini F; Invitti C; Dubini A; Danesi L; Silvestri G; Passamonti M; Magella A; Morabito F
    Adv Biochem Psychopharmacol; 1987; 43():273-81. PubMed ID: 3035891
    [No Abstract]   [Full Text] [Related]  

  • 15. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
    Inder WJ; Prickett TC; Mulder RT
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):343-8. PubMed ID: 15730417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the naloxone test with the insulin stress test in patients following transsphenoidal surgery.
    McAllister AS; McCance DR; Hadden DR; Bell PM; Leslie H; Sheridan B; Atkinson AB
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):261-5. PubMed ID: 10396371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality.
    Bradley AJ; Dinan TG
    J Psychopharmacol; 2010 Nov; 24(4 Suppl):91-118. PubMed ID: 20923924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-pituitary-adrenal axis in abdominal obesity: effects of dexfenfluramine.
    Boushaki FZ; Rasio E; Serri O
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):461-6. PubMed ID: 9196609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid modulation of the effects of repeated stress on ACTH, cortisol, prolactin, and growth hormone in pigs.
    Rushen J; Schwarze N; Ladewig J; Foxcroft G
    Physiol Behav; 1993 May; 53(5):923-8. PubMed ID: 8390062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid regulation of hypothalamic-pituitary-adrenal function in depression.
    Zis AP; Haskett RF; Albala AA; Carroll BJ; Lohr NE
    Arch Gen Psychiatry; 1985 Apr; 42(4):383-6. PubMed ID: 3977556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.